Results 171 to 180 of about 2,027,154 (268)

30 razones para 30 años de España en la Unión Europea [PDF]

, 2016
Parlamento Europeo. Servicio de Prensa
core  

India's Health Diplomacy: Advancing Pharmaceutical and MedTech Leadership in the Global South

World Medical &Health Policy, Volume 18, Issue 1, March 2026.
ABSTRACT Health diplomacy has become a pivotal aspect of India's engagement with the Global South, intertwining foreign policy, public health, and global collaboration to address disparities while pursuing strategic interests. India's pharmaceutical industry, which accounts for nearly 20% of the world's generics, has positioned the nation as the ...
Gaurav Chanderprakash Mittal, Vijay Kumar Chattu, Prakash Narayanan, Rahul Clare, Cherian Varghese   +4 more
wiley   +1 more source

Informe de producción y minimización de residuos año 2012 [PDF]

, 2013
Servicio de Protección Ambiental. UCO
core  

The OLGIMA system for gastric cancer risk assessment. A useful method based on the histological Sydney consensus

Histopathology, Volume 88, Issue 4, Page 911-921, March 2026.
The new OLGIMA method for histological gastric cancer risk assessment is based on the severity of glandular atrophy and intestinal metaplasia, in both antrum and corpus, according to the Updated Sydney classification. The highest score of either atrophy or intestinal metaplasia from each location will be used for the final OLGIMA stage.
Pedro Genaro Delgado Guillena, Miriam Cuatrecasas, Sheyla Montori, Nayra Felipez Varela, Joan Llach, Iva Archilla, Pablo Florez‐Diez, Eva Barreiro‐Alonso, Javier Tejedor‐Tejada, Raquel Vicente, M Teresa Soria, Alaín Huerta, Silvia Patricia Ortega, Henar Nuñez, Oliver Patrón, Carolina Mangas, Diana Zaffalon, Luis Hernández, Luis Enrique Yip, Gadea Hontoria, Gonzalo Hijos, Maria Jose Domper‐Arnal, Sara Zarraquiños, Alberto Herreros De Tejada, Alicia Córdoba, Anabella Cuestas, Glòria Fernández‐Esparrach, Leticia Moreira, Eduardo Albéniz, on behalf of EpiGASTRIC/EDGAR Consortium, Joan Llach, Sheyla Montori, Anabella Cuestas, Gloria Fernandez‐Esparrach, Nayra Felipez Varela, Fermín Estremera‐Arevalo, Marta Gómez Alonso, Juan José Vila Costas, Victoria Busto Bea, Juan Carrascosa Gil, Vanesa Jusué Irurita, Alicia Córdoba Iturriagagoitia, Concepción Llanos Chavarri, Irene Amat Villegas, Gregorio Aisa Rivera, Irene Fernández de los Reyes, Gina de Lima Piña, Miguel Ángel Resano, Adriana Yague Hernando, Cristina Caballero Martínez, Alfredo López Cousillas, Miriam Cuatrecasas, Pedro Genaro Delgado Guillena, Javier Tejedor, Elena Arruebo, Silvia Patricia Ortega, Henar Nuñez, Pilar Diez, Diana Zaffalon, Luis Hernández, Gadea Hontoria, Rosa Maria Saíz, Gonzalo Hijos, María Jose Domper, Sara Zarraquiños, Astrid Irene, Alberto Herreros, Diego de Frutos, Fatima Valentin, Jose Santiago, Virginia Piñol, Adelina García, Alicia Martín‐Lagos, Pablo Florez, Eva Barreiro, Adolfo Suarez, Raquel Vicente, M Teresa Soria, Cristina Polo, Carmen Yagüe, Alain Huerta, Oliver Patrón, David Tello, Carolina Mangas, Eva Serrano, Juan Martínez, Rodrigo Jover, Raquel Grajal, Luis Enrique Yip, Patricia Gonçalves, Jenifer Muñoz, Cristina Herrera‐Pariente, Laia Bonjoch, Sergi Castellví‐Bel, Dulce Momblan, Tamara Saurí, Irina Luzko, Elisa Cantú‐Germano, Angels Gines, Ignasi Elizalde, Francesc Balaguer, Angelez Perez‐Aisa, Jennifer Hinojosa, Coral Tejido, Laura Rivas, María Francisco, Manu Puga, Franco Baiocchi, Cristina Alejandra Sánchez, Alba Pereiros, Joaquin Cubiella, Alejandro Ledo, Ma Victoria Alvarez, Marta Garzón, Juan Manuel Martín, Salvador Sobrino, Ana García‐Rodríguez, Ines Gil, Alazne Aguirre, Ainara Maiz, Ines Ariño, María Dolores Pico, Beatriz de Riba, Goretti Hernández, Eduardo Albéniz, Leticia Moreira   +125 more
wiley   +1 more source

Iptacopan for Immune Thrombocytopenia and Cold Agglutinin Disease: A Global Phase 2 Basket Clinical Trial

American Journal of Hematology, Volume 101, Issue 2, Page 242-254, February 2026.
ABSTRACT Iptacopan is a first‐in‐class, oral, selective inhibitor of complement factor B that has demonstrated positive efficacy across several complement‐driven diseases. Here we evaluate the efficacy and safety of iptacopan monotherapy in adult patients with primary immune thrombocytopenia (ITP) and primary cold agglutinin disease (CAD). We performed
Alexander Röth, Wilma Barcellini, Christine Ademokun, Junho Jang, Maria Luisa Lozano, David Valcarcel Ferreiras, Cristina Pascual‐Izquierdo, Shripad Chitnis, Sofiya Matviykiv, Alessandra Vitaliti, Chi Chen, Vasiliki Katsanou, Raghav Chawla, Hanny Al‐Samkari   +13 more
wiley   +1 more source

Predictors of Progression in Pre-COPD: The 3P Study Rationale and Design. [PDF]

Open Respir Arch
González-Villaescusa C, Tarrasó Castillo J, Martínez-Pitarch D, Riesco Miranda JA, García-Castillo E, Gotera Rivera C, Carrasco Hernández L, Sobradillo Ecenarro P, Signes-Costa J, Naval Sendra E, Callejas González FJ, Yordi León A, Vigil Gimenez L, Núñez Fernández M, Palop Cervera M, Carbonell-Asins JA, Agusti A, Field Investigators.   +17 more
europepmc   +1 more source

Erratum: [Erratum] Tofacitinib Improves Motor Symptoms in Parkinsonism Associated with a Heterozygous NGLY1 Variant and Autoimmune Disease. [PDF]

Eur J Case Rep Intern Med
Reina-Llompart N, Serrano-López S, Torres-Iglesias G, Álvarez-Troncoso J.   +3 more
europepmc   +1 more source

Circular Economy: A Pathway to Integrated Value Creation for Business and Society

Business Strategy and the Environment, Volume 35, Issue 2, Page 2989-3017, February 2026.
ABSTRACT Amid growing environmental pressures and the pressing demand to advance sustainable development, the circular economy (CE) has positioned itself as a transformative business approach capable of safeguarding favourable ecosystem conditions through the application of key R‐strategies.
Saudi‐Yulieth Enciso‐Alfaro, Isabel‐María García‐Sánchez   +1 more
wiley   +1 more source

[Planetary health: The inescapable role of family medicine]. [PDF]

Aten Primaria
Galindo Ortega G, Del Campo Giménez M, Gutiérrez Muñoz B, Navarro Beltrá M, Almécija Pérez MC.   +4 more
europepmc   +1 more source

A Field‐Friendly, Non‐Toxic Fixative for Integrated Morphological and Molecular Research in Non‐Model Invertebrates

Ecology and Evolution, Volume 16, Issue 2, February 2026.
Formalin, ethanol, and RNAlater are commonly used fixatives for morphological and molecular studies, but each has limitations when specimen availability is low, as is often the case with field‐collected non‐model organisms. Here, we evaluate KINFix, a non‐toxic alcohol‐based fixative, in four invertebrate taxa and show that it effectively preserves ...
Irene del Olmo, Paula Moreno‐Martín, Patricia Álvarez‐Campos, Aida Verdes   +3 more
wiley   +1 more source